PEOPLE - Molecular Insight Pharmaceuticals makes appointment:
This article was originally published in Clinica
Former deputy commissioner for medical and scientific affairs at the US Centers for Medicare and Medicaid Services (CMS) Scott Gottlieb has become a board member at Molecular Insight Pharmaceuticals. The Cambridge, Massachusetts company will use his regulatory and reimbursement expertise as it develops its pipeline of molecular imaging pharmaceuticals and targeted radiotherapeutics for use in oncology and cardiology.
You may also be interested in...
Japanese big pharma Eisai taps Celgene and Sanofi execs as its new VPs for corporate affairs and market access. And Freeline Therapeutics, developer of gene therapies for bleeding disorders, selects a former Alnylam Pharma SVP as CEO.
After two Indian vaccine makers, Serum Institute of India and Cadila Healthcare joined the fight against COVID-19, Bharat Biotech may follow suit. Others like Hilleman have decided against it for the moment while Panacea Biotech is weighing the pros and cons of developing a SARS-CoV-2 vaccine after a sour experience with H1N1.